PDF Cover

Anti-Embolism Stockings Market

The market for Anti-Embolism Stockings was estimated at $1.1 billion in 2024; it is anticipated to increase to $1.6 billion by 2030, with projections indicating growth to around $2.3 billion by 2035.

Report ID:DS1806088
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Other Healthcare
Anti-Embolism Stockings
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Anti-Embolism Stockings Market Outlook

Revenue, 2024

$1.1B

Forecast, 2034

$2.2B

CAGR, 2025 - 2034

7.4%

The Anti-Embolism Stockings industry revenue is expected to be around $1.1 billion in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. Building on this steady growth trajectory, the anti-embolism stockings market continues to gain importance within the broader preventive healthcare and post-surgical care landscape. Increasing incidence of venous thromboembolism, rising number of surgical procedures, and growing awareness of preventive care are key factors driving demand. Healthcare providers are emphasizing cost-effective, non-invasive solutions to reduce complications during patient recovery, further strengthening market relevance. Additionally, aging populations and prolonged hospital stays are contributing to higher usage rates across hospitals and home care settings. Improvements in product design, comfort, and material quality are also supporting patient compliance, reinforcing the role of anti-embolism stockings as an essential component of thrombosis prevention strategies.

Anti-embolism stockings are specialized compression garments designed to improve blood circulation and reduce the risk of blood clot formation, particularly in immobile or post-operative patients. These stockings apply graduated pressure, with the highest compression at the ankle, gradually decreasing up the leg to promote venous return. They are widely used in hospitals, surgical recovery units, and home care environments for patients undergoing major surgeries or experiencing limited mobility. Key features include ease of use, non-invasive functionality, and compatibility with long-term care protocols. Recent trends highlight increasing adoption in outpatient care and home-based recovery, along with innovations in breathable fabrics and ergonomic designs, enhancing comfort and driving broader acceptance among patients and healthcare provid

Anti-Embolism Stockings market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Anti-Embolism Stockings Market Outlook

Market Key Insights

  • The Anti-embolism Stockings market is projected to grow from $1.1 billion in 2024 to $2.2 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Post-Surgical Recovery, Long Distance Travel, and Pregnancy.

  • Medtronic Plc, 3M Company, BSN Medical are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Anti Embolism Stockings market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.

  • Emerging markets including Brazil, South Africa and Indonesia are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.

  • Transition like Shift from Hospital-Centric Use to Home Care and Preventive Health Applications is expected to add $146 million to the Anti-embolism Stockings market growth by 2030.

  • The Anti Embolism Stockings market is set to add $1.1 billion between 2024 and 2034, with manufacturer targeting Home Care & Rehabilitation Centers Application projected to gain a larger market share.

  • With

    rising incidences of deep vein thrombosis, and

    Aging Global Population, Anti-embolism Stockings market to expand 104% between 2024 and 2034.

anti embolism stockings market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Anti-Embolism Stockings - Country Share Analysis

Opportunities in the Anti-Embolism Stockings

The increasing number of long-haul travelers presents a niche opportunity for anti-embolism stockings in the travel health segment. Mild compression stockings are gaining popularity among frequent flyers to prevent swelling and reduce the risk of travel-related deep vein thrombosis. Airlines, travel retailers, and wellness brands are promoting these products as essential travel accessories. Growth is also especially notable in Asia-Pacific and Europe, where international travel volumes are rising. Companies developing stylish, comfortable, and easy-to-wear variants are well positioned to expand in this consumer-driven segment.

Growth Opportunities in North America and Asia Pacific

North America represents a mature and high-value market for anti embolism stockings, supported by advanced healthcare infrastructure and strong awareness of thrombosis prevention. The region benefits from a high volume of surgical procedures and a growing elderly population, both of which drive consistent demand for compression therapy products. Top opportunities lie in home healthcare and outpatient recovery, where patients increasingly rely on anti embolism stockings for extended use. Competition is intense, with established medical device companies focusing on product innovation, comfort enhancements, and premium offerings. Reimbursement frameworks and physician recommendations further support adoption, while expanding retail and e-commerce channels improve accessibility, reinforcing steady market growth.
Asia-Pacific is emerging as a high-growth region for anti embolism stockings, driven by improving healthcare infrastructure, rising surgical volumes, and increasing awareness of venous health. Countries such as China and India are witnessing growing demand for affordable graduated compression stockings, particularly in hospitals and home care settings. Key opportunities exist in cost-effective product offerings and large-scale public health initiatives aimed at preventing deep vein thrombosis. Competition is intensifying as global and regional manufacturers expand their presence through distribution partnerships. Despite price sensitivity, rising disposable incomes and growing focus on preventive healthcare are supporting long-term market expansion.

Market Dynamics and Supply Chain

01

Driver: Rising Surgical Procedures Worldwide Coupled with Increasing Awareness of Thrombosis Prevention

The growing volume of surgical procedures globally is also a major driver for the anti-embolism stockings market. Factors such as aging populations, higher incidence of chronic diseases, and advancements in surgical techniques are also leading to increased hospital admissions and post-operative care needs. This directly boosts demand for preventive solutions like compression stockings to reduce the risk of venous thromboembolism. Simultaneously, rising awareness of thrombosis prevention among healthcare professionals and patients is also strengthening adoption. Hospitals are also increasingly incorporating anti-embolism stockings into standard care protocols, while educational initiatives are also highlighting their importance in reducing complications. Together, these factors are also enhancing product utilization across both inpatient and outpatient settings, supporting sustained market growth and reinforcing their role in preventive healthcare.
Technological advancements in compression textile manufacturing are also significantly driving the adoption of anti-embolism stockings. Innovations in breathable fabrics, moisture-wicking materials, and ergonomic designs are also improving patient comfort, making prolonged use more feasible. Modern stockings are also designed to provide consistent graduated compression while minimizing skin irritation and discomfort, addressing a key barrier to compliance. Additionally, the development of customizable sizes and user-friendly designs is also enhancing accessibility for diverse patient groups. These improvements are also particularly important in home care and long-term use scenarios, where patient adherence directly impacts treatment effectiveness, thereby supporting market expansion.
02

Restraint: Patient Non-Compliance and Application Difficulties Reducing Therapeutic Effectiveness and Demand

A major restraint in the anti-embolism stockings market is persistent patient non-compliance driven by discomfort, improper fit, and difficulty in wearing the product. Studies indicate a significant portion of patients either discontinue use or wear stockings incorrectly, reducing clinical effectiveness and weakening physician confidence in prescribing them. For example, elderly or post-surgical patients often struggle with application, leading to inconsistent usage and lower repeat demand. This directly impacts revenue generation and slows market penetration, especially in home care settings where supervision is limited, ultimately weakening long-term adoption rates.
03

Opportunity: Rising home healthcare adoption among elderly patients requiring thrombosis prevention and Innovation in maternity compression wear addressing pregnancy related circulation issues

A significant opportunity lies in the growing adoption of home healthcare services among elderly populations requiring long-term thrombosis prevention. Medical-grade anti-embolism stockings designed for ease of use and extended wear are increasingly utilized in home settings. As healthcare systems shift toward cost-effective outpatient care, patients are being discharged earlier, creating demand for reliable preventive solutions outside hospitals. This trend is particularly strong in North America and Europe, where aging demographics are prominent. Manufacturers focusing on user-friendly designs and caregiver-assisted products are expected to capture the most growth in this segment.
Pregnancy-specific compression stockings represent a growing opportunity within the anti-embolism stockings market. Maternity-focused designs offering gentle, graduated compression are increasingly recommended to manage swelling, varicose veins, and circulation challenges during pregnancy. This segment is gaining traction as awareness of preventive care improves among expecting mothers. Emerging markets in Asia and Latin America present untapped potential due to rising maternal healthcare awareness. Manufacturers investing in breathable fabrics, ergonomic fits, and aesthetically appealing designs are expected to drive demand, particularly in premium maternity and wellness product categories.
04

Challenge: High Product Costs and Limited Reimbursement Policies Restricting Accessibility and Market Expansion

High costs associated with medical-grade anti-embolism stockings, combined with inconsistent reimbursement policies, significantly limit market growth. Premium products and recurring replacement needs increase the financial burden on patients, particularly in low-income regions or where insurance coverage is limited. For instance, when stockings are categorized as out-of-pocket expenses, prescription volumes decline, reducing overall market revenue. Additionally, hospitals may prioritize alternative therapies or lower-cost options, impacting demand. These financial barriers create uneven market adoption and restrict expansion in price-sensitive healthcare systems.

Supply Chain Landscape

1

Raw Material Suppliers

DuPontINVISTA
2

Stocking Manufacturers

MedtronicBSN Medical
3

Distributors Wholesalers

McKesson CorporationCardinal Health
4

End-User Industry

HospitalsHome HealthcareAssisted Living Facilities
Anti-Embolism Stockings - Supply Chain

Use Cases of Anti-Embolism Stockings in Post-Surgical Recovery & Long Distance Travel

Post-Surgical Recovery : Post-surgical recovery remains the primary application for anti embolism stockings, where preventing venous thromboembolism is critical. In this setting, medical-grade graduated compression stockings are most commonly used due to their clinically proven effectiveness in improving blood circulation in immobilized patients. These stockings apply controlled pressure to the lower limbs, reducing the risk of clot formation during extended bed rest following surgeries such as orthopedic or abdominal procedures. Hospitals widely incorporate them into standard recovery protocols, often alongside other preventive measures. Increasing surgical volumes and emphasis on complication reduction continue to drive consistent demand in this segment.
Long Distance Travel : Long distance travel has emerged as a growing application area for anti embolism stockings, particularly among frequent flyers and individuals undertaking extended journeys. In this segment, mild to moderate compression stockings are typically used, offering comfort while promoting healthy blood flow during prolonged sitting. These stockings help reduce swelling, fatigue, and the risk of travel-related deep vein thrombosis. Their ease of use and availability in consumer-friendly designs have expanded adoption beyond medical settings. Rising awareness of travel-related health risks and increasing global mobility are supporting demand, especially in premium travel and wellness-oriented consumer segments.
Pregnancy : Pregnancy represents an important application for anti embolism stockings due to increased risk of circulatory issues and leg swelling. In this case, maternity-specific compression stockings are primarily used, designed to provide gentle, graduated pressure while ensuring comfort for extended wear. These stockings help alleviate symptoms such as edema, varicose veins, and leg discomfort, which are common during pregnancy. Healthcare professionals often recommend them as a preventive and supportive measure, particularly in later stages. Growing awareness among expecting mothers and expanding availability of specialized designs are contributing to rising adoption in both clinical and home care environments.

Impact of Industry Transitions on the Anti-Embolism Stockings Market

As a core segment of the Other Healthcare industry, the Anti-Embolism Stockings market develops in line with broader industry shifts. Over recent years, transitions such as Shift from Hospital-Centric Use to Home Care and Preventive Health Applications and Evolution from Basic Medical Compression to Lifestyle and Wellness-Oriented Products have redefined priorities across the Other Healthcare sector, influencing how the Anti-Embolism Stockings market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift from Hospital-Centric Use to Home Care and Preventive Health Applications

The anti embolism stockings market is transitioning from primarily hospital-based usage to broader adoption in home care and preventive health settings. This shift is driven by shorter hospital stays and increasing emphasis on outpatient recovery. Patients are now using compression stockings for extended periods at home, creating demand for more comfortable and user-friendly designs. For example, home healthcare providers are integrating these products into recovery kits, while pharmacies are expanding retail availability. This transition is also impacting the medical devices distribution industry, with greater focus on direct-to-consumer channels and caregiver-oriented solutions.
02

Evolution from Basic Medical Compression to Lifestyle and Wellness-Oriented Products

Another key transition is the evolution of anti embolism stockings from purely medical devices to lifestyle and wellness-oriented products. Manufacturers are introducing aesthetically appealing designs, improved fabrics, and multi-purpose compression wear that caters to both medical and everyday use. For instance, travel and maternity segments are increasingly adopting stylish compression stockings for preventive care. This shift is influencing adjacent industries such as apparel and wellness retail, where compression wear is being positioned as both functional and lifestyle-enhancing. As a result, companies are diversifying product portfolios to appeal to a broader consumer base.